NCT03594630View on ClinicalTrials.gov

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Rectal AdenocarcinomaStage II Rectal Cancer AJCC v8Stage IIA Rectal Cancer AJCC v8Stage IIB Rectal Cancer AJCC v8Stage IIC Rectal Cancer AJCC v8Stage III Rectal Cancer AJCC v8Stage IIIA Rectal Cancer AJCC v8Stage IIIB Rectal Cancer AJCC v8Stage IIIC Rectal Cancer AJCC v8
Interventions
DRUG

Chemotherapy

Receive chemotherapy

OTHER

Patient Observation

Receive active surveillance

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Resection of Rectum

Undergo surgical resection

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER